IGPA calls for TPP focus on generics

WASHINGTON — The International Generic Pharmaceutical Alliance has issued a statement calling on parties negotiating the Trans-Pacific Partnership to make access to affordable medication a priority.

According to IGPA, TPP, which is being negotiated by 12 countries including the U.S., in its current state “protects the interests of brand medicine manufacturers at the expense of public health.”

“IGPA supports trade agreements which promote the distribution of safe and affordable medicines and contribute to the sustainability of healthcare systems globally,” IGPA said. “Unfortunately, based on available information, TPP will threaten the right of “access to medicines for all” enshrined in the 2001 WTO Doha Declaration and recognized by all 12 TPP countries.”